Industry News
Peptech appoints new CEO
Sydney's Peptech (ASX:PTD) has appointed Dr John Chiplin as its new chief executive officer, effective January 2006. [ + ]
EvoGenix to optimise proteins for GlaxoSmithKline
GlaxoSmithKline (GSK) and EvoGenix (ASX:EGX) have signed a deal to apply the antibody developer's EvoGene technology to optimise selected compounds from GSK's product pipeline. [ + ]
Starpharma awarded landmark contract for VivaGel development
Melbourne drug developer Starpharma (ASX:SPL) has been awarded a US$20.3 million (AUD$26.4 million) contract from the US National Institutes of Health (NIH), for the development of its HIV preventative product VivaGel. [ + ]
Prime Minister's prizes for science
The annual Prime Minister's prizes for science and science teaching were awarded last night at Parliament House in Canberra. [ + ]
VitroGro now in powdered form
Protein chemists at Queensland University of Technology (QUT) have produced a new freeze-dried form of Brisbane-based Tissue Therapies' (ASX:TIS) wound-healing technology VitroGro. [ + ]
Orbis acquires 12 per cent of Acrux
Bermuda-based investment manager Orbis Mutual Funds has acquired a 12 per cent stake in Melbourne-based drug delivery company Acrux (ASX:ACR). [ + ]
Antisense 'proof-of-concept' study demonstrates activity of ATL1101 in psoriasis patients
Antisense Therapeutics (ASX:ANP) has produced positive results from a 'proof-of-concept' study of its second generation antisense drug ATL1101 to suppress the insulin-like growth factor-1 receptor (IGF-1R), which is under development as a cream for the topical treatment of the skin disorder psoriasis. [ + ]
pSivida acquires US drug delivery company
Perth nano-biotech company pSivida (ASX:PSD; NASDAQ:PSDV; Xetra:PSI) has agreed to purchase privately owned US drug delivery company Control Delivery Systems (CDS) for US$104 million (AUD$139 million), as part of its on-going US growth strategy. [ + ]
Resonance Health awarded WA FerriScan supply contract
Resonance Health Analysis Services (RHAS), a subsidiary of Perth-based Resonance Health (ASX:RHT), has been awarded a health supply contract from the government of Western Australia's department of health, for its FerriScan diagnostic test. [ + ]
Another 'grass roots' campaign gets feisty about GM
Could 'farmer power' force Australian state governments to back down on their moratoria on GM crops? Graeme O'Neill reports. [ + ]
VWR International and BDH Chemicals from Biolab
The full range of BDH chemicals and laboratory products including the AnalaR, ARISTAR, Spectrosol and GURR brands are now available again.
[ + ]OPINION: Is it time to redesign animal agriculture?
On the eve of a leading livestock conference, CSIRO Livestock Industries chief Shaun Coffey looks at why there are more questions than answers in agriculture -- and why scientists need to join in the debate. [ + ]
Brumby wants therapeutic cloning ban lifted
Victorian treasurer and minister for innovation, John Brumby, has called on the federal government to lift its ban on somatic cell nuclear transfer (SCNT), otherwise known as therapeutic cloning. [ + ]
DPI attracts international scientist
As part of a major scientific collaboration, the Department of Primary Industries (DPI) has appointed Canadian scientist, Dr Kim Lowell.
[ + ]Solbec granted patent
Solbec Pharmaceuticals (ASX:SBP) has been granted an Australian patent giving the company the monopoly right to prevent others from isolating the rhamnose binding protein receptor of its lead compound Coramsine. [ + ]
